Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Operating Income
Trinity Biotech PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Operating Income
-$15.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Medtronic PLC
NYSE:MDT
|
Operating Income
$6.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
STERIS plc
NYSE:STE
|
Operating Income
$846.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
15%
|
See Also
What is Trinity Biotech PLC's Operating Income?
Operating Income
-15.9m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Operating Income amounts to -15.9m USD.
What is Trinity Biotech PLC's Operating Income growth rate?
Operating Income CAGR 1Y
-45%
Over the last year, the Operating Income growth was -45%.